Annual Accounts Payable
$2.42 M
-$234.00 K-8.81%
December 31, 2023
Summary
- As of February 7, 2025, LSTA annual accounts payable is $2.42 million, with the most recent change of -$234.00 thousand (-8.81%) on December 31, 2023.
- During the last 3 years, LSTA annual accounts payable has risen by +$1.40 million (+137.35%).
- LSTA annual accounts payable is now -83.05% below its all-time high of $14.29 million, reached on December 1, 2010.
Performance
LSTA Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Accounts Payable
$556.00 K
-$172.00 K-23.63%
September 30, 2024
Summary
- As of February 7, 2025, LSTA quarterly accounts payable is $556.00 thousand, with the most recent change of -$172.00 thousand (-23.63%) on September 30, 2024.
- Over the past year, LSTA quarterly accounts payable has dropped by -$1.86 million (-77.03%).
- LSTA quarterly accounts payable is now -97.13% below its all-time high of $19.40 million, reached on March 1, 2012.
Performance
LSTA Quarterly Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Accounts Payable Formula
Accounts Payable = Beginning Accounts Payable + Purchases on Credit − Payments to Suppliers
LSTA Accounts Payable Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | -8.8% | -77.0% |
3 y3 years | +137.3% | -77.0% |
5 y5 years | +217.7% | -77.0% |
LSTA Accounts Payable Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3-year | -8.8% | +25.2% | -79.1% | at low |
5 y | 5-year | -8.8% | +137.3% | -79.1% | +768.8% |
alltime | all time | -83.0% | >+9999.0% | -97.1% | +823.6% |
Lisata Therapeutics Accounts Payable History
Date | Annual | Quarterly |
---|---|---|
Sep 2024 | - | $556.00 K(-23.6%) |
Jun 2024 | - | $728.00 K(-42.4%) |
Mar 2024 | - | $1.26 M(-47.8%) |
Dec 2023 | $2.42 M(-8.8%) | $2.42 M(+84.5%) |
Sep 2023 | - | $1.31 M(+69.3%) |
Jun 2023 | - | $775.00 K(-42.2%) |
Mar 2023 | - | $1.34 M(-49.5%) |
Dec 2022 | $2.65 M(+37.3%) | $2.65 M(+172.6%) |
Sep 2022 | - | $974.00 K(-11.2%) |
Jun 2022 | - | $1.10 M(+57.4%) |
Mar 2022 | - | $697.00 K(-64.0%) |
Dec 2021 | $1.93 M(+89.6%) | - |
Dec 2021 | - | $1.93 M(+151.8%) |
Sep 2021 | - | $768.00 K(-38.2%) |
Jun 2021 | - | $1.24 M(-46.3%) |
Mar 2021 | - | $2.31 M(+127.0%) |
Dec 2020 | $1.02 M(-31.5%) | $1.02 M(-7.7%) |
Sep 2020 | - | $1.10 M(+86.7%) |
Jun 2020 | - | $592.00 K(+825.0%) |
Mar 2020 | - | $64.00 K(-95.7%) |
Dec 2019 | $1.49 M(+95.5%) | $1.49 M(+76.5%) |
Sep 2019 | - | $844.00 K(+51.0%) |
Jun 2019 | - | $559.00 K(+1.1%) |
Mar 2019 | - | $553.00 K(-27.4%) |
Dec 2018 | $762.00 K(-43.3%) | $762.00 K(+70.4%) |
Sep 2018 | - | $447.20 K(-11.6%) |
Jun 2018 | - | $505.70 K(-41.7%) |
Mar 2018 | - | $866.80 K(-35.5%) |
Dec 2017 | $1.34 M(-39.7%) | $1.34 M(+52.7%) |
Sep 2017 | - | $879.60 K(-21.0%) |
Jun 2017 | - | $1.11 M(-68.9%) |
Mar 2017 | - | $3.58 M(+60.7%) |
Dec 2016 | $2.23 M(-45.8%) | $2.23 M(-31.4%) |
Sep 2016 | - | $3.25 M(+11.8%) |
Jun 2016 | - | $2.90 M(-27.1%) |
Mar 2016 | - | $3.98 M(-3.0%) |
Dec 2015 | $4.11 M(-27.4%) | $4.11 M(+66.5%) |
Sep 2015 | - | $2.47 M(+8.9%) |
Jun 2015 | - | $2.27 M(-22.6%) |
Mar 2015 | - | $2.93 M(-48.3%) |
Dec 2014 | $5.66 M(+68.7%) | $5.66 M(+28.7%) |
Sep 2014 | - | $4.40 M(-19.7%) |
Jun 2014 | - | $5.48 M(+66.3%) |
Mar 2014 | - | $3.30 M(-1.8%) |
Dec 2013 | $3.35 M(+31.3%) | $3.35 M(+8.5%) |
Sep 2013 | - | $3.09 M(+28.2%) |
Jun 2013 | - | $2.41 M(+10.0%) |
Mar 2013 | - | $2.19 M(-14.2%) |
Dec 2012 | $2.56 M(+11.7%) | $2.56 M(-0.6%) |
Sep 2012 | - | $2.57 M(+18.4%) |
Jun 2012 | - | $2.17 M(-88.8%) |
Mar 2012 | - | $19.40 M(+748.0%) |
Date | Annual | Quarterly |
---|---|---|
Dec 2011 | $2.29 M(-84.0%) | $2.29 M(-76.9%) |
Sep 2011 | - | $9.90 M(+6.8%) |
Jun 2011 | - | $9.27 M(-25.3%) |
Mar 2011 | - | $12.40 M(-13.2%) |
Dec 2010 | $14.29 M(+72.9%) | $14.29 M(+87.4%) |
Sep 2010 | - | $7.62 M(-18.5%) |
Jun 2010 | - | $9.35 M(+5.0%) |
Mar 2010 | - | $8.91 M(+7.8%) |
Dec 2009 | $8.26 M(+1524.2%) | $8.26 M(+2316.3%) |
Sep 2009 | - | $342.00 K(+104.1%) |
Jun 2009 | - | $167.60 K(-77.4%) |
Mar 2009 | - | $742.60 K(+46.0%) |
Dec 2008 | $508.80 K(+221.0%) | $508.80 K(+48.3%) |
Sep 2008 | - | $343.20 K(+148.2%) |
Jun 2008 | - | $138.30 K(+38.6%) |
Mar 2008 | - | $99.80 K(-37.0%) |
Dec 2007 | $158.50 K(-57.4%) | $158.50 K(+5.1%) |
Sep 2007 | - | $150.80 K(-68.6%) |
Jun 2007 | - | $479.90 K(+144.8%) |
Mar 2007 | - | $196.00 K(-47.4%) |
Dec 2006 | $372.30 K(+44.9%) | $372.30 K(+518.4%) |
Sep 2006 | - | $60.20 K(-85.0%) |
Jun 2006 | - | $401.20 K(-11.9%) |
Mar 2006 | - | $455.40 K(+77.2%) |
Dec 2005 | $257.00 K(+7.9%) | $257.00 K(-63.7%) |
Sep 2005 | - | $707.60 K(+230.8%) |
Jun 2005 | - | $213.90 K(+4.7%) |
Mar 2005 | - | $204.30 K(-14.2%) |
Dec 2004 | $238.10 K(+170.9%) | $238.10 K(+4.7%) |
Sep 2004 | - | $227.40 K(+67.7%) |
Jun 2004 | - | $135.60 K(+8.1%) |
Mar 2004 | - | $125.40 K(+42.7%) |
Dec 2003 | $87.90 K(-74.5%) | $87.90 K(-7.9%) |
Sep 2003 | - | $95.40 K(-81.5%) |
Jun 2003 | - | $516.20 K(+20.8%) |
Mar 2003 | - | $427.40 K(+24.1%) |
Dec 2002 | $344.30 K(+163.6%) | $344.30 K(+29.0%) |
Sep 2002 | - | $266.90 K(+2.9%) |
Jun 2002 | - | $259.30 K(+61.8%) |
Mar 2002 | - | $160.30 K(+22.7%) |
Dec 2001 | $130.60 K(-9.8%) | $130.60 K(+20.5%) |
Sep 2001 | - | $108.40 K(+11.9%) |
Jun 2001 | - | $96.90 K(0.0%) |
Mar 2001 | - | $96.90 K(-33.1%) |
Dec 2000 | $144.80 K(-74.2%) | $144.80 K(-28.1%) |
Sep 2000 | - | $201.50 K(-1.2%) |
Jun 2000 | - | $203.90 K(+50.7%) |
Mar 2000 | - | $135.30 K |
Dec 1999 | $561.90 K(+319.6%) | - |
Dec 1998 | $133.90 K(+161.5%) | - |
Mar 1998 | $51.20 K(+944.9%) | - |
Mar 1997 | $4900.00(-97.3%) | - |
Mar 1996 | $183.10 K | - |
FAQ
- What is Lisata Therapeutics annual accounts payable?
- What is the all time high annual accounts payable for Lisata Therapeutics?
- What is Lisata Therapeutics annual accounts payable year-on-year change?
- What is Lisata Therapeutics quarterly accounts payable?
- What is the all time high quarterly accounts payable for Lisata Therapeutics?
- What is Lisata Therapeutics quarterly accounts payable year-on-year change?
What is Lisata Therapeutics annual accounts payable?
The current annual accounts payable of LSTA is $2.42 M
What is the all time high annual accounts payable for Lisata Therapeutics?
Lisata Therapeutics all-time high annual accounts payable is $14.29 M
What is Lisata Therapeutics annual accounts payable year-on-year change?
Over the past year, LSTA annual accounts payable has changed by -$234.00 K (-8.81%)
What is Lisata Therapeutics quarterly accounts payable?
The current quarterly accounts payable of LSTA is $556.00 K
What is the all time high quarterly accounts payable for Lisata Therapeutics?
Lisata Therapeutics all-time high quarterly accounts payable is $19.40 M
What is Lisata Therapeutics quarterly accounts payable year-on-year change?
Over the past year, LSTA quarterly accounts payable has changed by -$1.86 M (-77.03%)